Skip to main content
Top
Literature
1.
go back to reference Merle B, Garnero P (2012) The multiple facets of periostin in bone metabolism. Osteoporos Int 23(4):1199–1212PubMedCrossRef Merle B, Garnero P (2012) The multiple facets of periostin in bone metabolism. Osteoporos Int 23(4):1199–1212PubMedCrossRef
2.
3.
go back to reference Li M, Li C, Li D et al (2012) Periostin, a stroma-associated protein, correlates with tumor invasiveness and progression in nasopharyngeal carcinoma. Clin Exp Metastasis 29(8):865–877PubMedCrossRef Li M, Li C, Li D et al (2012) Periostin, a stroma-associated protein, correlates with tumor invasiveness and progression in nasopharyngeal carcinoma. Clin Exp Metastasis 29(8):865–877PubMedCrossRef
5.
go back to reference Kharaishvili G, Cizkova M, Bouchalova K, Mgebrishvili G, Kolar Z, Bouchal J (2011) Collagen triple helix repeat containing 1 protein, periostin and versican in primary and metastatic breast cancer: an immunohistochemical study. J Clin Pathol 64:977–982PubMedCrossRef Kharaishvili G, Cizkova M, Bouchalova K, Mgebrishvili G, Kolar Z, Bouchal J (2011) Collagen triple helix repeat containing 1 protein, periostin and versican in primary and metastatic breast cancer: an immunohistochemical study. J Clin Pathol 64:977–982PubMedCrossRef
6.
go back to reference Kyutoku M, Taniyama Y, Katsuragi N et al (2011) Role of periostin in cancer progression and metastasis: inhibition of breast cancer progression and metastasis by anti-periostin antibody in a murine model. Int J Mol Med 28:181–186PubMed Kyutoku M, Taniyama Y, Katsuragi N et al (2011) Role of periostin in cancer progression and metastasis: inhibition of breast cancer progression and metastasis by anti-periostin antibody in a murine model. Int J Mol Med 28:181–186PubMed
7.
go back to reference Morra L, Rechsteiner M, Casagrande S et al (2012) Characterization of periostin isoform pattern in non-small cell lung cancer. Lung Cancer 76:183–190PubMedCrossRef Morra L, Rechsteiner M, Casagrande S et al (2012) Characterization of periostin isoform pattern in non-small cell lung cancer. Lung Cancer 76:183–190PubMedCrossRef
9.
go back to reference Utispan K, Sonongbua J, Thuwajit P et al (2012) Periostin activates integrin α5β1 through a PI3K/AKT dependent pathway in invasion of cholangiocarcinoma. Int J Oncol 41:1110–1118PubMed Utispan K, Sonongbua J, Thuwajit P et al (2012) Periostin activates integrin α5β1 through a PI3K/AKT dependent pathway in invasion of cholangiocarcinoma. Int J Oncol 41:1110–1118PubMed
10.
go back to reference Fujimoto K, Kawaguchi T, Nakashima O et al (2011) Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma. Oncol Rep 25:1211–1216PubMedCrossRef Fujimoto K, Kawaguchi T, Nakashima O et al (2011) Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma. Oncol Rep 25:1211–1216PubMedCrossRef
11.
go back to reference Utispan K, Sonongbua J, Thuwajit P, Chau-In S, Pairojkul C, Wongkham S, Thuwajit C (2012) Periostin activates integrin a5ß1 through a PI3K/AKT-dependent pathway in invasion of cholangiocarcinoma. Int J Oncol 41(3):1110–1118 Utispan K, Sonongbua J, Thuwajit P, Chau-In S, Pairojkul C, Wongkham S, Thuwajit C (2012) Periostin activates integrin a5ß1 through a PI3K/AKT-dependent pathway in invasion of cholangiocarcinoma. Int J Oncol 41(3):1110–1118
Metadata
Title
Periostin and its emerging role in systemic carcinogenesis
Author
S. Kapoor
Publication date
01-04-2014
Publisher
Springer London
Published in
Osteoporosis International / Issue 4/2014
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-013-2614-0

Other articles of this Issue 4/2014

Osteoporosis International 4/2014 Go to the issue